4th Quarter - Report

FOLEY HOAG LLP for SPECTRUM PHARMACEUTICALS

Firm
Client
Income
$5,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Budget Control Act of 2011 (P.L. 112-25) (Part B payment)

LobbyistCovered position, as disclosed
BRIAN CAREY —
PAUL KIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA authority for notification of drug shortages; S. 296 and H.R. 2245 Preserving Access to Life-Saving Medications Act

LobbyistCovered position, as disclosed
BRIAN CAREY —
PAUL KIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 296 (112th), H.R. 2245 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.